Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

J. Samol; I. Demedts; M. Erman; V. Kozlov; J. N. Minatta; F. V. Moiseenko; M. S. Paats; S. J. Rajappa; T. Bailey; H. Wallis; M. Madondo; D. Kahangire; M. Zukin

Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

J. Samol
, I. Demedts
, M. Erman
, V. Kozlov
, J. N. Minatta
, F. V. Moiseenko
, M. S. Paats
, S. J. Rajappa
, T. Bailey
, H. Wallis
, M. Madondo
, D. Kahangire
, M. Zukin

Tan Tock Seng Hospital
Pulm Dis
Dept Prevent Oncol
University of Buenos Aires
Chemotherapy Dept
Erasmus University Rotterdam
Adelphi Group Ltd
AstraZeneca
Dept Med Oncol

Araştırma sonucu: Dergiye katkı › Toplantı Özeti › bilirkişi

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	S55-S56
Sayfa sayısı	2
Dergi	Journal of Thoracic Oncology
Hacim	18
Basın numarası	4
Yayın durumu	Yayınlandı - Nis 2023

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

SKH 3 Sağlık ve Kaliteli Yaşam

Diger dosyalar ve linkler

???wos.publication.link???

Bundan alıntı yap

Samol, J., Demedts, I., Erman, M., Kozlov, V., Minatta, J. N., Moiseenko, F. V., Paats, M. S., Rajappa, S. J., Bailey, T., Wallis, H., Madondo, M., Kahangire, D., & Zukin, M. (2023). Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries. Journal of Thoracic Oncology, 18(4), S55-S56.

@article{d075668b7e7c4316a287e19ccaa57788,

title = "Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries",

author = "J. Samol and I. Demedts and M. Erman and V. Kozlov and Minatta, \{J. N.\} and Moiseenko, \{F. V.\} and Paats, \{M. S.\} and Rajappa, \{S. J.\} and T. Bailey and H. Wallis and M. Madondo and D. Kahangire and M. Zukin",

year = "2023",

month = apr,

language = "English",

volume = "18",

pages = "S55--S56",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

Samol, J, Demedts, I, Erman, M, Kozlov, V, Minatta, JN, Moiseenko, FV, Paats, MS, Rajappa, SJ, Bailey, T, Wallis, H, Madondo, M, Kahangire, D & Zukin, M 2023, 'Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries', Journal of Thoracic Oncology, hac. 18, no. 4, pp. S55-S56.

TY - JOUR

T1 - Real-world use of tyrosine kinase inhibitors (TKI) in epidermal growth factor receptor mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) in nine countries

AU - Samol, J.

AU - Demedts, I.

AU - Erman, M.

AU - Kozlov, V.

AU - Minatta, J. N.

AU - Moiseenko, F. V.

AU - Paats, M. S.

AU - Rajappa, S. J.

AU - Bailey, T.

AU - Wallis, H.

AU - Madondo, M.

AU - Kahangire, D.

AU - Zukin, M.

PY - 2023/4

Y1 - 2023/4

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000995007600027&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1556-0864

VL - 18

SP - S55-S56

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -